Friday, 13 July 2012

Biopharmaceutical Company Bavarian Nordic-Public Health Emergency-Atopic Dermatitis

Bavarian says U.S. expands group eligible for Imvamune

COPENHAGEN (Reuters) - Danish biopharmaceutical company Bavarian Nordic said on Wednesday the U.S. Government had expanded the population eligible to receive its attenuated smallpox vaccine, Imvamune, during an emergency. The company said on Wednesday that in the event of a public health emergency involving smallpox, the government may now authorize the use of Imvamune to protect individuals of all ages with HIV infection or atopic dermatitis (AD), a type of eczema. ... read more..

No comments:

Post a Comment